Molecular Hydrogen and Epilepsy: What the Research Shows
I originally wrote this article in 2022 after a parent asked me what the molecular-hydrogen research might mean for epilepsy and seizures. At the time, much of the case I could make was based on biological overlap: oxidative stress, neuroinflammation, astrocyte activation, mitochondrial dysfunction, glutamate excitotoxicity, GABA signaling, and the gut–brain axis.
Those mechanistic connections still matter, and now we have more direct evidence to consider. Investigators have published studies of molecular hydrogen and seizure activity, including refractory status epilepticus in rats, hypoxic–ischemic seizures in newborn piglets, kainic-acid-induced seizures in rats, and a 2026 randomized double-blind human trial in children with infantile epileptic spasm syndrome.
That does not make every study equivalent, and it does not mean every form of epilepsy will respond the same way. What it does mean is that the question has progressed from “Does H₂ regulate pathways that matter in epilepsy?” to the more direct question: “What happens when molecular hydrogen is actually studied in seizure and epilepsy models?”
H2HUBB Takeaway
- The biological rationale has become stronger. Direct seizure studies now connect H₂ with several of the same pathways that originally caught my attention, including oxidative stress, Nrf2, inflammatory cytokines, astrocytes, microglia, NMDA/NR2B signaling, neuronal survival, and cerebral blood flow.
- Direct preclinical evidence is now more substantial. Multiple animal studies have reported reductions in seizure intensity, EEG activity, seizure burden, status-epilepticus duration, or seizure-related neuronal injury under specific H₂ protocols.
- Human translation has begun. A 2026 randomized double-blind trial studied a 66.6% H₂/33.3% O₂ mixture as an adjunct to standard treatment in children with infantile epileptic spasm syndrome. The short 14-day intervention did not significantly improve the main efficacy outcomes compared with air, which is an important finding for interpreting the current state of the evidence.
- Administration method matters. Hydrogen-rich saline, low-concentration H₂ gas, and high-concentration hydrogen/oxygen mixtures are different interventions. Dose, concentration, timing, duration, disease model, age, and delivery method all matter when we compare studies.
What the Newer Seizure Research Shows
What interests me most about the newer research is that investigators are now testing several of these mechanistic connections inside actual seizure models rather than looking only at related neurological pathways.
Hydrogen-Rich Saline Reduced EEG Activity and NR2B Phosphorylation
In a pilocarpine model of refractory status epilepticus, hydrogen-rich saline lowered EEG amplitudes and significantly reduced phosphorylation of the NMDA-receptor subunit NR2B. The researchers also reported increased mitochondrial SOD2 and reduced neuronal death through lower oxidative stress. Behavioral Racine scores did not significantly differ between groups, so the result is more specific than simply saying “hydrogen stopped the seizures.”
H₂ Plus Therapeutic Hypothermia Reduced Seizure Burden
Newborn piglets exposed to hypoxic–ischemic injury received therapeutic hypothermia alone or therapeutic hypothermia plus 2.1–2.7% H₂ for 24 hours. The combined H₂ group had a lower percentage of abnormal aEEG backgrounds and a shorter duration of status epilepticus, supporting a direct connection between H₂ exposure and seizure burden in this translational model.
H₂ Inhalation Reduced Seizure Intensity, Neuroinflammation and Oxidative Stress
Rats inhaled H₂ for two hours once daily for five days before kainic-acid administration. H₂ pretreatment attenuated seizure intensity, reduced neuronal loss, decreased microglial and astrocytic activation, lowered ROS and inflammatory mediators including TNF-α, IL-1β, IL-6, CCL2 and CCL3, increased Nrf2, and helped preserve cerebral blood flow. This study directly connects several of the pathways I discussed in 2022 with an actual seizure model.
View the PubMed record ↗
View it in the H2HUBB Research Library →
The First Direct Randomized Human Trial Did Not Show Added Short-Term Efficacy
Fifty-three children with infantile epileptic spasm syndrome completed a randomized double-blind trial comparing standard treatment plus a 66.6% H₂/33.3% O₂ mixture with standard treatment plus medical air. The intervention was delivered by face mask at 3 L/min for one hour, four times daily, for 14 days. The groups did not differ significantly in spasm relief, treatment effectiveness, disappearance of hypsarrhythmia, EEG scores, or IL-6 abnormality.
How I Interpret the 2026 Human Trial
I would not ignore the short-term efficacy result, but I also would not use one small, 14-day study to erase the broader preclinical evidence. From our position at H2HUBB, this trial answers a very narrow question: this particular 14-day, 66.6% H₂/33.3% O₂ protocol did not add a statistically significant short-term benefit to standard IESS treatment. That is useful information, but it is not the same as showing that molecular hydrogen has no therapeutic potential for epilepsy.
In fact, the investigators themselves identified the short treatment duration as one possible explanation for the result, noting that 14 days may have been too brief for hydrogen’s neuroprotective effects to fully manifest. They specifically called for future studies to examine longer treatment courses, different hydrogen concentrations, treatment frequency, dose-response relationships, larger patient groups, and longer follow-up. I would add administration route to that list as well, because hydrogen-rich water, lower-concentration H₂ inhalation, and high-concentration H₂/O₂ mixtures should not automatically be treated as equivalent interventions.
This also fits a larger question in molecular-hydrogen research: whether repeated H₂ exposure over longer periods may produce biological effects that are difficult to capture in a short intervention. Experimental research has proposed that H₂ can influence adaptive cellular pathways—including Nrf2-related antioxidant signaling and mitohormetic responses—rather than acting only as a short-lived direct antioxidant. That gives us a reasonable mechanistic basis for studying short-term protocols measured in days or weeks versus longer-form therapy measured in months. However, we still need controlled human epilepsy trials before we can say what treatment duration is optimal.
The safety findings should also be kept in proportion. No serious adverse events occurred, the overall incidence of adverse reactions was comparable between groups, and the authors described the intervention as generally safe and feasible. The study therefore gives researchers additional safety signals to monitor in future trials rather than establishing that molecular hydrogen harms children.
When I look at the evidence as a whole, the trend remains encouraging. Multiple preclinical seizure and neurological-injury models have reported reductions in seizure burden or seizure-related injury alongside effects on oxidative stress, neuroinflammation, Nrf2 signaling, astrocytes, microglia, and neuronal protection. The first short human IESS trial did not confirm a significant added benefit over 14 days, but it also did not close the question. It opens the door to better-designed human studies examining optimal dose, administration route, treatment duration, frequency, disease subtype, and combinations with standard therapy.
That is why my current position at H2HUBB remains that molecular hydrogen has health and therapeutic potential for epilepsy, while definitive clinical answers still require more human research. Given H₂’s generally favorable safety profile across the broader clinical literature and the substantial overlap between the pathways it influences and mechanisms involved in epilepsy, it is reasonable for families interested in H₂ to discuss it with a qualified clinician as a possible adjunct to—not a replacement for—standard epilepsy care.
Read research discussing H₂ and adaptive/mitohormetic cellular responses ↗
Explore the Molecular Hydrogen Research Directly
H2HUBB’s Research Library organizes molecular-hydrogen studies by disease area, administration method, study type, mechanisms, outcomes, and publication details so you can move beyond individual quotes and inspect the underlying literature.
Why I Originally Wrote This Article
I first wrote about this subject after a parent asked me what the molecular-hydrogen research might mean for a child dealing with epilepsy. I deliberately used the phrase “health potential for epilepsy” because the direct epilepsy literature was limited, while the biological overlap was already difficult to ignore. My goal was to connect what we knew about epilepsy biology with what molecular hydrogen was already doing in neurological, inflammatory, oxidative-stress, and mitochondrial models.
The purpose was not to claim that every form of epilepsy had the same cause. It was to ask whether H₂ was regulating systems that repeatedly show up in the pathophysiology of seizures and epilepsy—and then look for direct research wherever it existed. That is still the framework I use below.
I also included some information on H₂ and autism because the parent I was corresponding with had asked about both subjects.
“Hello,
Thank you for contacting us. I reviewed your email and will gladly address your inquiries.
First, there are many disease models that have been investigated with molecular hydrogen (>170 human and animal diseases) but the medical or biomedical research into molecular hydrogen is still in its infancy. We need far more research before we can start taking more definitive stands on hydrogen therapy, especially for particular disease models. Therefore, in this email, as I do with every other email, I will speak of molecular hydrogen’s therapeutic potential or promise regarding your current situation.
Now, the potential therapeutic targets hydrogen regulates based on etiological (causal) factors I am sharing may not apply to all forms of epilepsy but there are common ictogenesis characteristics or mechanisms they share that are part of the pathophysiology of epilepsy or seizures. These targets include, but are not limited to, Astrocytes (Astrogliosis), Glutamate (excitotoxicity), GABA, Oxidative stress, Neuro-inflammation, Mitochondrial dysfunction, gut microbiome, etc. As stated, this list is not exhaustive; I left out Ghrelin (hunger hormone), Leptin (satiety hormone), and Lipid Peroxidation, all of which have been linked to Epilepsy, and all regulated by hydrogen gas to produce therapeutic effects. I decided to go through the effort of compiling some of the data to help you see that molecular hydrogen appears to regulate, modulate, or influence many of these targets that have emerged as central players in the possible cause and progression of epilepsy disorders. The quotations on the causal markers provide indirect evidence that supports the idea that molecular hydrogen may have therapeutic potential for Epilepsy. Furthermore, I gathered a couple of molecular hydrogen studies that focus on disease models that can lead to or exhibit seizures or epilepsy. These sources provide more direct evidence that molecular hydrogen may offer promise for your child’s situation. Lastly, I grabbed some studies on hydrogen and autism. The same process can be done for autism and more and more studies are being done in these areas due to the promising preliminary studies.
Note: Even if the entirety of this information was not provided to you, the sheer fact that we have a growing body of human evidence that molecular hydrogen is safe to use, reduces oxidative stress systemically, has demonstrated systemic anti-inflammatory effects in multiple research models, and is advantageous for the mitochondria and immune system makes it a noteworthy candidate for your kiddo’s situation.
Possible Etiological Markers:
Oxidative Stress
Oxidative stress—the dysregulation of our free-radical and antioxidant systems—appears to be closely connected with the onset, initiation, and progression of epilepsy in multiple models. Molecular hydrogen has repeatedly been studied for its ability to reduce oxidative stress and regulate endogenous antioxidant defenses.
Epilepsy: Oxidative stress is involved in the pathogenesis of a number of neurologic conditions and neurodegenerative disorders, including Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, and epilepsy (Perry et al., 2002; Migliore et al., 2005; Ashrafi et al., 2007). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3606551/
“Epilepsy is a highly prevalent serious brain disorder, and oxidative stress is regarded as a possible mechanism involved in epileptogenesis. Experimental studies suggest that oxidative stress is a contributing factor to the onset and evolution of epilepsy.” https://pubmed.ncbi.nlm.nih.gov/22848783/
“Epilepsy, characterized by a long-term predisposition to epileptic seizures, is one of the most common of the neurological disorders associated with OS (oxidative stress). Evidence shows that increased neuronal excitability-the hallmark of epilepsy-is accompanied by neuroinflammation and an excessive production of ROS; together, these factors are likely key features of seizure initiation and propagation.” https://pubmed.ncbi.nlm.nih.gov/35052661/
Molecular Hydrogen:
“Our results indicated that low concentration of H2 in drinking water can reduce oxidative stress in the brain.” https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0007247
“Recently it was also shown that drinking H2-saturated water, instead of inhaling H2 gas, prevents cognitive impairment by reducing oxidative stress [3]. According to Nagata et al. [3], even in drinking water, H2 can be delivered to the blood in minutes.” https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0007247
“Inhalation of molecular hydrogen (H2) gas ameliorates oxidative stress-induced acute injuries in the brain. Consumption of water nearly saturated with H2 also prevents chronic neurodegenerative diseases including Parkinson’s disease in animal and clinical studies.” https://pubmed.ncbi.nlm.nih.gov/28467497/
“The consumption of H2-rich water inhibits oxidative stress and thereby inhibits the onset of stress-induced brain damage.(43)” https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5525017/
Neuroinflammation
Molecular hydrogen is a biologically active gas that is increasingly discussed in the context of gaseous signaling molecules. Its effects appear to extend beyond direct radical scavenging and include regulation of gene expression, redox signaling, inflammatory pathways, and cellular stress responses. Since neuroinflammation is a major feature in many epilepsy models, this gives us another biologically plausible connection between molecular hydrogen and seizure-related brain injury.
Epilepsy:
“In the process of epileptogenesis, neuroinflammation commonly occurs after acute brain injuries and lowers the seizure threshold, thereby contributing to a persistent state of neuronal network hyperexcitability.” https://www.nature.com/articles/s41582-019-0217-x#:~:text=In%20the%20process%20of%20epileptogenesis,state%20of%20neuronal%20network%20hyperexcitability.
“Based on evidence that neuroinflammation contributes to set seizure threshold and occurs before the onset of epilepsy in animals exposed to status epilepticus, neurotrauma, or hyperthermia, pharmacological studies targeted potentially pathogenic inflammatory pathways during epileptogenesis.” https://journals.sagepub.com/doi/10.1177/1535759720948900
“Blocking neuroinflammation can be especially effective in counteracting the cascade mechanisms of recurrent seizures. As a future perspective, it would be important to explore if a pretreatment with anti-inflammatory drugs could block the emergence of seizures in subjects that are prone to epilepsy because of genetic diseases, brain trauma, tumors, infections, or SARS-COV2.” https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267969/
“Many studies have explored the interaction between neuroinflammation and neurological disorders, particularly with epilepsy [7,8]. Epilepsy can be a primary pathology, due to structural or genetic reasons, or a secondary effect. In the latter case, it can be a consequence of traumatic brain injuries and brain tumors; then, it can be related to an infectious, metabolic, immune or unknown etiology, as summarized in the last ILAE classification of the epilepsies [9]. Undoubtedly, the presence of certain chronic inflammatory diseases facilitates epilepsy or other neurological manifestations. Indeed, in most autoimmune diseases, there is a five-fold increased risk of epilepsy in children and a four-fold increased risk in non-elderly adults (aged < 65) [10,11]. Even though the impaired regulation of the inflammatory response in injured neuronal tissue is a critical factor to the development of epilepsy, it is still unclear how this unbalanced regulation of inflammation contributes to epilepsy [8]. On the other hand, several studies have shown that epileptogenesis produces long-term effects on neuroinflammation, worsening the progression and outcome of epilepsy [7,8,12,13,14].” https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267969/
“Neuroinflammation is proposed to contribute to the neurobiology of both autism and epilepsy (14-17). Recently, anti-inflammatory and immunosuppressive drugs have showed promising therapeutic effects in autism (18) and epilepsy.” https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4322506/
Molecular Hydrogen:
“HS treatment prevented neuro-inflammation and behavioral dysfunction following HI insult.” https://link.springer.com/article/10.1186/s12974-019-1488-2
“One of hydrogen’s greatest potentials is the exciting findings indicating it may act as a potential prophylactic neurodegenerative agent. Research on therapeutic Hydrogen has gathered considerable evidence demonstrating results in neurodegenerative diseases such as a 52 week human trial on mild cognitive impairment68, Alzheimer’s6970 and Parkinson’s717273, benefits in protection from cognitive impairment/decline747576777879808182, rodent models on central nervous system diseases such as ALS83 and MS84, reduction of neuroinflammation8586 and recovery from stroke878889 and traumatic brain injuries90. Hydrogen has also been shown to induce secretion of ghrelin91 which has demonstrated neuroprotective capabilities.9293 On top of Hydrogen’s ability to protect against both long-term deterioration in our brain, as well as acute injury, it has shown to positively affect mood, anxiety, and depression both in rodent and human models,949596 as well as reducing autistic-like behaviors in mice.97”
“Inhalation of hydrogen gas attenuates brain injury in mice with cecal ligation and puncture via inhibiting neuroinflammation, oxidative stress and neuronal apoptosis.” https://pubmed.ncbi.nlm.nih.gov/25251596/
“Molecular hydrogen reduces LPS-induced neuroinflammation and promotes recovery from sickness behaviour in mice.” https://pubmed.ncbi.nlm.nih.gov/22860058/
“Biological gaseous molecules, also referred as gasotransmitters, including nitric oxide (NO), carbon monoxide (CO), hydrogen sulfide (H2S), and molecular hydrogen (H2), also serve critical roles in mammals’ physiological and pathological conditions (Zhou et al., 2012). They can easily cross the blood–brain barrier (BBB) and spread through brain tissue due to their smaller molecular weights compared with chemically formulated drugs (Zhou et al., 2012; Deng et al., 2014). Accumulating evidence has demonstrated that these gaseous molecules provide neuroprotection in many diseases of the central nervous system (CNS) through different mechanisms and administration regimens (Ren et al., 2010; Charriaut-Marlangue et al., 2012; Zhan et al., 2012; Otterbein, 2013).” https://www.frontiersin.org/articles/10.3389/fnins.2018.00392/full
Astrocytes (Astrogliosis) — Glial Cells in the CNS and Brain
Astrocytes are abundant glial cells within the central nervous system and perform a wide range of functions involving neurotransmitter balance, ion homeostasis, metabolic support, and inflammatory signaling. Excessive or dysfunctional astrocyte activation—often discussed as reactive astrogliosis—has become an important part of the epilepsy conversation. Molecular hydrogen has been shown in experimental models to reduce excessive astrocyte activation and astrogliosis, which creates another mechanistic connection worth following.
Epilepsy:
“Recent studies have implicated that astrocytes play important roles in physiology, but these cells also emerge as crucial actors in epilepsy.” https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4355248/
“These findings suggest that dysfunctional astrocytes are crucial players in epilepsy and should be considered as promising targets for new therapeutic strategies.” https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4355248/
“The pivotal role played by astrocytes in regulating normal brain functions clearly extends to a pathophysiologic role in epilepsy. As is discussed above, astrocytes play a number of essential roles in brain function, including regulation of K+ and glutamate homeostasis, as well as in the supply of neurotransmitter precursors for reuse at excitatory and inhibitory synapses. These normal functions are all significantly perturbed in epilepsy. Associated with the development of gliosis (e.g. Astrogliosis) in the brains of patients with epilepsy and in animal models of this disorder, there is accumulating evidence for loss of appropriate K+ homeostasis and accompanying changes in aquaporin, gap-junction expression and function, compromised uptake and metabolism of glutamate in astrocytes, and disrupted neurotransmitter supply, particularly in inhibitory neurons. In addition to being potentially linked with gliosis, these biochemical changes have significant functional consequences, contributing to the circuit hyperexcitability that is the hallmark of epilepsy. This further implicates compromised astrocyte dysfunction in the pathophysiology of epilepsy. In addition to providing new information about causal factors in epilepsy development and expression, this role of astrocytes suggests new avenues for therapeutic interventions with significant promise.” https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4355248/
“Changes in astrocyte channels, transporters, and metabolism play a critical role in seizure generation and epilepsy. In particular, alterations in astrocyte potassium, glutamate, water and adenosine homeostasis and gap junctional coupling have all been associated with hyperexcitability and epileptogenesis (largely in temporal lobe epilepsy). Distinct astrocytic changes have also been identified in other types of epilepsy, such as tuberous sclerosis, tumor-associated epilepsy and post-traumatic epilepsy. Together, the emerging literature on astrocytes and epilepsy provides powerful rationale for distinct new therapeutic targets that are astrocyte-specific.” https://link.springer.com/article/10.1007/s11064-021-03236-x
“Furthermore, excessive astrocyte activation may cause other detrimental effects that were not investigated in this study, involving damnifying blood-brain barrier function by vascular endothelial growth factor (VEGF) production, releasing excitotoxic glutamate, inducing cytotoxic edema through AQP4 over activity, and contributing to chronic pain and seizures 1,” https://onlinelibrary.wiley.com/doi/full/10.1111/cns.12258
Molecular Hydrogen:
“The above results verified that molecular hydrogen could suppress the astrogliosis and related inflammation after SCI and oxidative injury. Anti-astrogliosis may be a neuroprotective mechanism of molecular hydrogen.” https://onlinelibrary.wiley.com/doi/full/10.1111/cns.12258
“These results further demonstrated that the functional activation of astrocytes, due to H2O2‐induced oxidative injury, was decreased by hydrogen‐rich medium.” https://onlinelibrary.wiley.com/doi/full/10.1111/cns.12258
“H2 suppresses expression of S100 calcium-binding protein B (S100B), phosphorylation of C-Jun N-terminal kinase (JNK), and reactive astrogliosis through reduction of ROS and lower neuronal cell damage in several rat disease models” https://www.nature.com/articles/s41598-020-69028-5.pdf?origin=ppub
“We found that HS (hydrogen saline) could reduce the content of IL‐1β, IL‐6, and TNF‐α in the spinal cord during the acute period (POD 3; HS vs. NS, P < 0.01, P < 0.01, and P < 0.05, respectively; Figure 1A). This means that triggers of astrogliosis can be attenuated by HS.” https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6493038/
“We also showed that the analgesic effect of hydrogen-rich normal saline was associated with decreased activation of astrocytes and microglia, attenuated expression of interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) in the spinal cord.” https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4032255/
“HS could inhibit the major signaling pathway of astrogliosis.” https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6493038/
Mitochondrial Dysfunction
Mitochondria are central to cellular bioenergetics, calcium handling, redox balance, and cell survival. When mitochondrial function is compromised, neurons may become more vulnerable to oxidative stress, excitotoxicity, and energetic failure. Mitochondrial dysfunction is increasingly implicated in epilepsy and seizure-related neuronal injury. Molecular hydrogen has also been studied for effects on mitochondrial oxidative stress, ATP production, respiratory function, apoptosis, and related signaling pathways, making mitochondria an important part of this discussion.
Epilepsy:
“The role of mitochondrial dysfunction arising from mitochondrial DNA mutation/depletion has been shown to be the cause of certain types of epilepsy.” https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3606551/
“The brain is particularly susceptible to oxidative damage due to its high aerobic metabolic demand and high iron load (Halliwell, 1992). The brain is rich in mitochondria, the principal source of cellular superoxide (O2-) formed during respiration (Turrens et al., 1982). It is plausible that prolonged seizures result in sufficient O2- production to overwhelm the endogenous mitochondrial antioxidant defenses by a cascade of events initiated by increased neuronal firing, excessive glutamate release, N-methyl-D-aspartate (NMDA) receptor activation, cytosolic and mitochondrial calcium influx, and increased ATP consumption.” https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3606551/
Molecular hydrogen:
“Molecular hydrogen is a novel antioxidant to efficiently reduce oxidative stress with potential for the improvement of mitochondrial diseases” https://pubmed.ncbi.nlm.nih.gov/21621588/
“HS (Hydrogen saline) markedly increased the antioxidant potential of mitochondria, as evidenced by elevated adenosine triphosphate levels, mitochondrial respiratory function, and increased levels of active Bcl‑2. In conclusion, HS attenuates mitochondrial oxidative stress and dysfunction, and inhibits mitochondrial-mediated apoptosis in the livers of BDL mice.” https://pubmed.ncbi.nlm.nih.gov/26936224/
“Our study showed that hydrogen-rich saline was able to attenuate neuronal I/R injury, probably by protecting mitochondrial function in rats.” https://pubmed.ncbi.nlm.nih.gov/24969549/
“Collectively, the results demonstrated that H2 alleviated mitochondrial dysfunction and cytokine release via autophagy-mediated NLRP3 inflammasome inactivation.” https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713420/
“Preliminary clinical trials show that drinking hydrogen-dissolved water seems to improve the pathology of mitochondrial disorders.” https://pubmed.ncbi.nlm.nih.gov/21621588/
Glutamate — Excitatory Neurotransmission
Glutamate is the brain’s principal excitatory neurotransmitter, and excessive glutamatergic signaling can contribute to excitotoxicity, neuronal injury, and seizure propagation. This is especially relevant to epilepsy because NMDA-receptor signaling and glutamate homeostasis are closely tied to neuronal excitability. Molecular hydrogen has been studied in models of glutamate-induced cellular stress and, more recently, in direct seizure research involving the NMDA receptor subunit NR2B.
Epilepsy:
“Glutamate is the principal excitatory neurotransmitter in the brain and, as such, it inevitably plays a role in the initiation and spread of seizure activity. It also plays a critical role in epileptogenesis.” https://pubmed.ncbi.nlm.nih.gov/7970002/
“This imbalance is related to increased extracellular glutamate in the brain and/or reduction in GABA concentrations, leading to excitotoxicity, seizures, and cell death.” https://pubmed.ncbi.nlm.nih.gov/34233236/
“Glutamatergic synapses (synapses that produce Glutamate) play a critical role in all epileptic phenomena” https://www.sciencedirect.com/science/article/abs/pii/S0079612308604495?via%3Dihub
Molecular hydrogen:
“The current study further revealed that ERW (Hydrogen water) significantly suppresses cell death caused by glutamate or SNP-induced stresses although it does not have direct NO scavenging activity. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4212634/
“ERW (hydrogen water) significantly suppressed glutamate-induced cell death which is closely correlated with reduced Ca2+ influx.” https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4212634/
“ERW was also reported to possess reducing activities because of the presence of dissolved molecular hydrogen [57, 58].” https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4212634/
“Based on these studies, it is highly probable that hydrogen molecules in ERW can reach and deliver a neuroprotective effect in the brain.” https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4212634/
GABA — Inhibitory Neurotransmission
Glutamate is the major excitatory neurotransmitter in the brain, while GABA is the major inhibitory neurotransmitter. The balance between these systems is central to neuronal excitability and seizure control. Lower or impaired GABAergic inhibition has been linked to epileptogenesis. The connection I see here is more indirect: molecular hydrogen can regulate inflammatory mediators and signaling molecules—including TNF-α and pathways related to hydrogen sulfide (H₂S)—that can themselves influence GABAergic signaling. That does not establish H₂ as a direct GABA therapy, but it gives us another pathway worth investigating.
Epilepsy:
“Our results suggest that glutamatergic and GABAergic synapses are synergistically regulated by TNF-α, strengthening and weakening glutamatergic and GABAergic synapses, respectively, which leads to a synaptic imbalance.” https://journals.plos.org/plosbiology/article/file?id=10.1371/journal.pbio.3000307&type=printable
“Hydrogen sulfide (H2S) is recognized as a new neuromodulator in regulating various brain functions. Some of our recent studies showed that H2S alleviates the hippocampal damage induced by recurrent febrile seizures (FS). In the present study, we used a rat model of recurrent FS and found that sodium sulfhydrate (NaHS, a donor of H2S) down-regulated the expression of c-fos and increased the expression of gamma-aminobutyric acid B receptor subunits 1 (GABABR1) and 2 (GABABR2).” https://pubmed.ncbi.nlm.nih.gov/16122826/
“gamma-Aminobutyric acid (GABA) is considered to be the major inhibitory neurotransmitter in the brain and loss of GABA inhibition has been clearly implicated in epileptogenesis.” https://pubmed.ncbi.nlm.nih.gov/11475940/
“These recent findings indicate that the GABA transporter plays a much more dynamic role in control of brain excitability than has previously been recognized.” https://pubmed.ncbi.nlm.nih.gov/15250587/
Molecular hydrogen:
“Furthermore, HRW administration significantly reversed the alternation of serum levels of interleukin 6 (IL-6) and tumor necrosis factor-α (TNF-α), but without any effects on the BDNF levels in maternal VPA-exposed mice offspring. These data suggest the need for additional research on HRW as a potential preventive strategy for autism and related disorders.” https://www.frontiersin.org/articles/10.3389/fnbeh.2018.00170/full
“In addition, hydrogen water reduced levels of TNF-α and IL-6, which mediate inflammatory responses. Therefore, hydrogen water is efficacious in the treatment of neonatal HIE.” https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5329859/
“Our results showed that hydrogen (H2) up-regulated H2S levels via promoting the expression of CBS in the hippocampus, and its treatment alleviated oxidative stress via activating the expression of Nrf2 and HO-1, and then cell apoptosis reduced, furthermore, brain function improved by down-regulating the levels of S100-βand NSE.” https://ijbms.mums.ac.ir/article_14868.html
Gut Microbiome and the Gut–Brain Axis
In recent years, the gut–brain axis has become increasingly important in neurological research. Alterations in the gut microbiome have been reported in epilepsy, and microbial metabolites, immune signaling, intestinal permeability, and vagal pathways may all influence neuronal excitability and neuroinflammation. Molecular hydrogen is naturally produced in the human gut by microbial fermentation, and exogenous H₂ has also been studied for effects on gut-barrier integrity, intestinal inflammation, short-chain fatty-acid signaling, and microbiome composition. That makes the gut another plausible route through which H₂ could influence systems relevant to epilepsy.
Epilepsy:
“The close relationship between epilepsy and autoimmune diseases and the fact that the cause of epilepsy is idiopathic in 60% of cases suggest that intestinal microbiota may play a role in the etiology of epilepsy.” https://www.sciencedirect.com/science/article/abs/pii/S0882401019304917?via%3Dihub
“Normalization of the intestinal microbiota may be a new treatment for epilepsy.”
“On the contrary, in many neurological diseases, such as in ASD and epilepsy, an alteration in gut microbiota has been shown [129,130,131,132,133,134].” https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267969/
“Moreover, several alterations in gut microbiota associated with intestinal problems have been found in other neuropsychiatric disorders of potential neurodevelopmental origins, such as schizophrenia [128,135,136,137], bipolar disorder [138] and depression [139,140], where the balance between excitation and inhibition is impaired [141].” https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267969/
“Recently, evidence from both animal studies and human cases has emerged that a dysbiosis in the gut may be associated with certain forms of epilepsy.” https://pubmed.ncbi.nlm.nih.gov/31160269/
“Several studies demonstrate a microbiota-gut-brain bidirectional connection via neural, endocrine, metabolic and immune pathways.” https://pubmed.ncbi.nlm.nih.gov/31626816/
“Accordingly, the gut microbiota has a crucial role in modulating intestinal permeability, to alter local/peripheral immune responses and in production of essential metabolites and neurotransmitters. Its alterations may consequently influence all these pathways that contribute to neuronal hyper-excitability and mirrored neuroinflammation in epilepsy and similarly other neurological conditions. Indeed, pre- and clinical studies support the role of the microbiome in pathogenesis, seizure modulation and responses to treatment in epilepsy. Up to now, researchers have focused attention above all on the brain to develop antiepileptic treatments, but considering the microbiome, could extend our possibilities for developing novel therapies in the future.” https://pubmed.ncbi.nlm.nih.gov/31626816/
Molecular hydrogen:
“Exogenous H2 (hydrogen water, H2 inhalation, etc) reprograms colonocyte metabolism by regulating the H2–gut microbiota–SCFAs axis and strengthens the intestinal barrier by modulating specific mucosa-associated mucolytic bacteria, wherein improved microbial hydrogen economy alleviates colitis.” https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759589/
“Taken together, the evidence indicates that HRW administration helps maintain permeability, mucosal structure and barrier function in the intestine and improves the gastrointestinal microenvironment for bacteria that protect against EtOH-induced liver injury.” https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5526762/
“Hydrogen inhalation significantly improved bowel motility 24 h after reperfusion (N = 6 each group) (B)” https://onlinelibrary.wiley.com/doi/full/10.1111/j.1600-6143.2008.02359.x?regionCode=US-KS&identityKey=c982340a-0b86-4c68-80c5-6d4cf231264a&wol1URL=%2Fdoi%2F10.1111%2Fj.1600-6143.2008.02359.x%2Ffull
“These findings suggest that H2 improves LPS-induced hyperpermeability of the intestinal barrier and disruptions of TJ and AJ by moderating RhoA-mDia1 signaling.” https://pubmed.ncbi.nlm.nih.gov/26529665/
“These results suggest luminal administration of hydrogen-rich saline, which prevents intestinal dysbiosis, hyperpermeability, and bacterial translocation, could potentially be a new therapeutic strategy in critical illness.” https://pubmed.ncbi.nlm.nih.gov/29293174/
“Furthermore, the consumption of hydrogen-rich water improved the diversity and abundance of the gut flora in athletes.” https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6352569/
“Thus, the consumption of hydrogen-rich water for two months might play a role modulating in the gut flora of athletes based on its selective antioxidant and anti-inflammatory activities.” https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6352569/
“These results suggest that saturated hydrogen could improve intestinal structural integrity and lipid metabolism disorders by inhibiting the glyoxylic acid cycle of the intestinal flora.” https://pubmed.ncbi.nlm.nih.gov/31910652/
Molecular Hydrogen Studies Reporting Reduced Seizure Burden or Seizure-Related Injury
“They added 2.4 percent hydrogen gas to the animals’ usual ventilation gases during and after arrested blood flow and hypoxia. Compared with controls, the treated animals did significantly better on neurologic evaluations. They had fewer seizures, smaller areas of tissue injury on brain MRI and decreased chemical markers of brain and kidney injury in their blood.” https://www.sciencedaily.com/releases/2019/04/190429140617.htm
“Two swine in the control group exhibited refractory status epilepticus and were sacrificed at 32 and 36 h post-injury following a failed trial of extubation; no hydrogen-treated animals exhibited seizures.”
“We have shown that the perioperative administration of 2.40% H2 is safe and diminishes neurologic injury in an experimental model of circulatory arrest. Although the combination of temperature and duration of circulatory arrest used is not used clinically, the model did successfully establish the degree of neurologic injury manifested in the most severely affected neonates, including perioperative seizures and radiographically apparent injury. In that setting, the perioperative administration of H2 improved clinical neurologic scores, decreased serum markers of brain injury, decreased radiographically apparent volumes of brain injury, and lessened the degree of histopathologic injury. In addition, H2-treated swine exhibited a significantly lower concentration of serum creatinine during the survival period, suggesting that hydrogen may diminish the effects of renal ischemia.” https://basictranslational.onlinejacc.org/content/4/2/176
“Because most CA patients may not get advanced life support immediately, we applied the 2-hour 60% H2 treatment starting 1 hour after resuscitation. This approach tended to reduce the incidence of seizures and improve neurological deficit scores in the resuscitated rats. However, the time of H2 administration seems to play an important role in that early administration has been shown to be associated with more significant benefits in previous studies.[18],[22],[23] https://www.medgasres.com/article.asp?issn=2045-9912;year=2018;volume=8;issue=3;spage=73;epage=78;aulast=Huang
Closing
Studies for Hydrogen and Autism:
Physical exercise and intermittent administration of lactulose may improve autism symptoms through hydrogen production https://medicalgasresearch.biomedcentral.com/articles/10.1186/2045-9912-2-19
Hydrogen-rich water ameliorates autistic-like behavioral abnormalities in valproic acid-treated adolescent mice offspring (Jul 2018) https://www.frontiersin.org/articles/10.3389/fnbeh.2018.00170/abstract
Ghanizadeh, A., Hydrogen as a novel hypothesized emerging treatment for oxidative stress in autism.European Review for Medical and Pharmacological Sciences, 2012. 16(9): p. 1313-4. https://www.researchgate.net/publication/232225514_Hydrogen_as_a_novel_hypothesized_emerging_treatment_for_oxidative_stress_in_autism
The neuroprotective effects of electrolyzed reduced water and its model water containing molecular hydrogen and Pt nanoparticles – autism http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3285010/
Oxidative stress in autism http://www.sciencedirect.com/science/article/pii/S0928468006000538
Oxidative and environmental stress http://link.springer.com/article/10.1007/s13273-012-0029-1
Hydrogen as a novel hypothesized emerging treatment for oxidative stress in autism http://www.europeanreview.org/article/1469
I hope this gives you enough information on molecular hydrogen and its potential for your kiddos. I know a lot of it may be hard to understand, but I wanted to give you a genuine look at the data to understand its potential. I cannot imagine what you have been through trying to love on your kids and help them with their health challenges, but I do believe molecular hydrogen holds potential for your family. You mentioned your budget is limited, but without a ballpark dollar amount, it’s hard to recommend a particular H2 product. Based on the research it would be best to have them consume both hydrogen water and hydrogen inhalation, as they both have their unique advantages and disadvantages. Hydrogen water will be better for gut health and H2 inhalation for increasing H2 in the brain and CNS.
So with that being said here are a couple of recommendations.
H2 water:
H2 Inhalation:
These are some of the more budget-friendly options.
I hope this blesses you.
Let me know how I can help you further.
One thing I want to clarify about administration route: Hydrogen water can be especially attractive when I am thinking about gastrointestinal exposure, while inhalation delivers H₂ through the lungs into systemic circulation and the CNS. But I do not think we should assume one route is universally “better.” Hydrogen dose, dissolved concentration, inhaled H₂ concentration, ventilation, session length, timing, device design, and the specific disease model all change the biological exposure. The research should guide the protocol rather than the other way around.
Molecular Hydrogen and Epilepsy: Frequently Asked Questions
Has molecular hydrogen been studied directly for seizures or epilepsy?
Yes. Direct preclinical research now includes refractory status epilepticus, kainic-acid-induced seizures, hypoxic–ischemic seizure models, and neonatal brain-injury models. A 2026 randomized double-blind clinical trial also evaluated a high-concentration hydrogen/oxygen mixture as an adjunct to standard treatment in children with infantile epileptic spasm syndrome.
What mechanisms could connect molecular hydrogen with epilepsy?
The main connections discussed in this article include oxidative stress and redox regulation, Nrf2 signaling, neuroinflammation, cytokines, astrocytes and microglia, mitochondrial function, glutamate/NMDA signaling, GABA-related inhibitory balance, neuronal apoptosis, cerebral blood flow, and the gut–brain axis. Not every mechanism applies equally to every epilepsy syndrome.
Did the 2026 human epilepsy trial show that hydrogen worked?
The 14-day randomized double-blind IESS trial did not show a statistically significant added benefit for its main seizure or EEG efficacy outcomes compared with medical air when both groups also received standard treatment. It was still an important translational milestone because it moved molecular hydrogen into a direct randomized pediatric epilepsy study and generated safety and protocol information for future research.
Is hydrogen-rich water the same intervention as hydrogen inhalation?
No. Both deliver molecular hydrogen (H₂), but the exposure pattern is different. Hydrogen water is limited by dissolved H₂ concentration, serving volume, timing, and how quickly the water is consumed. Inhalation depends on gas production, H₂ concentration, ventilation, breathing pattern, cannula or mask delivery, and session duration. High-concentration hydrogen/oxygen mixtures are another distinct category and should not be treated as equivalent to low-concentration pure-H₂ protocols.